CMS Names New Compendium to Approved List for Off Label Coverage Determinations

by Laura E. Loeb View Biography
King & Spalding LLP View Firm Credentials
Washington Office

Mark Smith
King & Spalding LLP View Firm Credentials
Atlanta Office

More...

Articles by this author

Articles by this firm

Articles by this topic

June 26, 2008

Previously published on June 9, 2008

On June 5, 2008, CMS added the National Comprehensive Cancer Network (NCCN) Drugs & Biologics Compendium to its list of approved sources for making off-label coverage determinations for Part B anti-cancer drugs.

Start New Search

View the full text of this article

The views expressed in this article are solely the views of the author and not Martindale-Hubbell. This article is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance.

Search Legal Topics

CMS Names New Compendium to Approved List for Off Label Coverage Determinations

More...